Kefu Cai

Kefu Cai

Auto-generated profile, based on publicly available information

Kefu Cai

Department of Neurology, Affiliated Hospital of Nantong University, Nantong, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2017 in Neurological Research
Verified
Journal Article
Closed access
BXBin Xu
Bin Xu
QJQiuhong Ji
Qiuhong Ji
YZYunfeng Zhang
Yunfeng Zhang
LSLihua Shen
Lihua Shen
MCMaohong Cao
Maohong Cao
KCKefu Cai
Kefu Cai
Objective: The present study was conducted to evaluate the effect of postoperative blood pressure (BP) variability on functional outcome in patients after coil embolization of ruptured aneurysms. Methods: The authors retrospectively reviewed their database of patients undergoing endovascular coiling to treat subarachnoid hemorrhage (SAH) between November 2011 and December 2014. BP values were recorded every 2 hours in the initial 24 hours after endovascular obliteration of ruptured aneurysms. BP variability was determined as standard deviation (SD) and successive variation (SV). Clinical outcome at discharge was assessed by the modified Rankin Scale (mRS) and Glasgow Coma Scale (GCS) Score. BP variability obtained were correlated to patient outcome and analyzed statistically. Results: Favorable outcomes (mRS 0–1) achieved in 308 (83.7%) of the 368 patients. On univariate logistic analysis, postoperative systolic blood pressure variability (SBPV)-SD, SBPV-SV, diastolic blood pressure variability (DBPV)-SD and DBPV-SV were associated with clinical outcome at discharge. SBPV-SV remained to be an independent predictor for functional recovery (OR, 0.93; 95% CI, 0.88–0.98; P = 0.009) after adjusting for age, postoperative fever, and Hunt–Hess grade by multivariate analysis. Furthermore, patients with higher SBPV had lower GCS grade at discharge (P < 0.001). There was no association between clinical outcome and mean systolic BP (SBP) (P = 0.360) or mean diastolic BP (DBP) (P = 0.105) after coiling. Conclusion: Postoperative SBPV was a strong predictor of clinical outcome in patients undergoing coil embolization of aneurysms, independent of mean SBP or DBP and seemed to be a potential therapeutic target in aneurysmal SAH.

26 July 2018 in Neurological Research
Verified
Journal Article
Closed access
KCKefu Cai
Kefu Cai
YNYaohui Ni
Yaohui Ni
YZYunfeng Zhang
Yunfeng Zhang
LSLihua Shen
Lihua Shen
QJQiuhong Ji
Qiuhong Ji
MCMaohong Cao
Maohong Cao
Objective: to evaluate whether postoperative heart rate variability (HRV) predicts short-term outcomes in patients undergoing coil embolization of ruptured aneurysms. Methods: Consecutive patients receiving endovascular coiling to treat aneurysmal subarachnoid hemorrhage (SAH) were retrospectively reviewed between November 2011 and December 2014 in the authors’ institution. Heart rate (HR) and blood pressure (BP) recorded in the initial 24 h after endovascular treatment were extracted along with other clinical data. HR variability (HRV) and BP variability (BPV) were determined as standard deviation (SD) and successive variation (SV) of every 2-h HR and BP. The correlation between HRV and clinical outcomes as assessed by Glasgow Outcome Scale (GOS) scores at discharge were analyzed statistically. Results: Compared to the 310 patients with favorable outcomes (GOS 4–5), the 35 with unfavorable outcomes (GOS 1–3) had significantly higher HR, HRV, and BPV in the first postoperative day. Furthermore, HRV-SD remained to be an independent predictor of unfavorable recovery in multivariate logistic analysis (OR = 1.14; 95% CI, 1.02–1.29; P = 0.026) after adjusting for age, postoperative fever, and Glasgow Coma Scale scores on admission, which have been identified as predictors of poor prognosis. The area under the receiver operating characteristic curves for HRV-SD and BPV-SV were found to be 0.745 (95% CI, 0.658–0.833) and 0.633 (95% CI, 0.524–0.741), respectively (P < 0.05). Conclusions: Higher HRV in the first day after coil embolization was associated with unfavorable outcomes in patients with SAH. Early detection and appropriate treatment of the overactive sympathetic activity might promote functional recovery after SAH. Abbreviation: BP: Blood pressure; CI: Confidence interval; DBP: Diastolic blood pressure; GCS: Glasgow coma scale; GOS: Glasgow outcome scale; HR: Heart rate; HRV: Heart rate variability; OR: Odds ratio; ROC: Receiver operating characteristics; SD: Standard deviation; SAH: Subarachnoid hemorrhage; SV: Successive variation; SBP: Systolic blood pressure

1 December 2009 in Neuroscience Letters
Verified
Journal Article
Closed access
KCKefu Cai
Kefu Cai
QDQing Di
Qing Di
JSJingPing Shi
JingPing Shi
YZYing-Dong Zhang
Ying-Dong Zhang

21 January 2016 in World Neurosurgery
Verified
Journal Article
Closed access
PDF file
KCKefu Cai
Kefu Cai
TXTian Xu
Tian Xu
LSLihua Shen
Lihua Shen
YNYaohui Ni
Yaohui Ni
QJQiuhong Ji
Qiuhong Ji

19 October 2023 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
HTHuimin Tao
Huimin Tao
QWQi Wan
Qi Wan
MSMei Sun
Mei Sun
KCKefu Cai
Kefu Cai
YSYan Song
Yan Song
JSJiabing Shen
Jiabing Shen
Objectives: Patients with medication-overuse headache (MOH) are often complicated with anxiety, depression, and sleep disorders and are associated with dependence behavior and substance abuse. Melatonin has physiological properties including analgesia, regulation of circadian rhythms, soporific, and antidepressant and affects drug preference and addiction. This study aimed to investigate the role of melatonin in MOH compared with episodic migraine (EM) and healthy controls and to verify the relationship between plasma melatonin levels and psychiatric symptoms. Methods: Thirty patients affected by MOH, 30 patients with EM, and 30 matched healthy controls were enrolled. All subjects completed a detailed headache questionnaire and scales including the Hospital Anxiety and Depression Scale (HADS), the Pittsburgh Sleep Quality Index, the Leeds Dependence Questionnaire. Melatonin levels in plasma samples were measured by enzyme immunoassay method. Results: The levels of plasma melatonin were significantly different among 3 groups of subjects (MOH, 7.74 [5.40–9.89]; EM, 9.79 [8.23–10.62]; Control, 10.16 [8.60–17.57]; H = 13.433; P = 0.001). Significantly lower levels of melatonin were found in MOH patients compared with healthy controls (P = 0.001). The level of plasma melatonin inversely correlated with the scores of HADS-Anxiety (r = −0.318, P = 0.002), HADS-Depression (r = −0.368, P < 0.001), Pittsburgh Sleep Quality Index (r = −0.303, P = 0.004), and Leeds Dependence Questionnaire (r = −0.312, P = 0.003). Conclusions: This study innovatively detects the plasma melatonin levels in MOH patients and explores the association between melatonin levels and psychiatric symptoms. Melatonin may be potential complementary therapy in the treatment of MOH considering its comprehensive role in multiple aspects of MOH.

1 July 2024 in Alzheimer Disease & Associated Disorders
Verified
Journal Article
Closed access
YWYuqin Mm Wang
Yuqin Mm Wang
HTHuimin Mm Tao
Huimin Mm Tao
MCMaohong Cao
Maohong Cao
KCKefu Cai
Kefu Cai
Urinary Alzheimer-associated neuronal thread protein (AD7c-NTP) is regarded as a biomarker for β-amyloid protein deposition in Alzheimer disease (AD). The value of AD7c-NTP in predicting post-stroke cognitive recovery was worth exploring. In total, 224 patients with first-ever stroke were enrolled in this retrospective study. Cognitive assessment was evaluated by Mini-Mental State Examination (MMSE), and cognitive improvement was defined as MMSE scores ≥27 or 4-score elevation at 3-month follow-up after stroke. The AD7c-NTP level was 0.68±0.40 ng/mL in the 135 patients with cognitive improvement, while the AD7c-NTP level was 1.49±0.99 ng/mL in the 89 patients without improvement (P<0.001). Those displaying better cognitive recovery also had younger ages, higher MMSE scores, and lower NIHSS scores on admission. In multivariable logistic regression analysis, AD7c-NTP concentration (OR=9.14, 95% CI: 4.52-18.49, P<0.001), age (OR=1.04, 95% CI: 1.01-1.08, P=0.012), and NIHSS score on admission (OR=1.17, 95% CI: 1.07-1.28, P<0.001) remained the independent risk factors affecting cognitive recovery. The area under the receiver operating characteristics curve for AD7c-NTP in predicting unfavorable cognitive function was 0.80 (sensitivity: 0.73 and specificity: 0.84). Urinary AD7c-NTP is a valuable biomarker associated with post-stroke cognitive recovery. It might be adopted to discriminate coexisting AD pathology from vascular cognitive impairment.